Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Bicycle Therapeutics nets $60.4mm through US IPO

Executive Summary

Peptide therapeutics developer Bicycle Therapeutics Ltd. competed its IPO on the Nasdaq, netting $60.4mm through the sale of 4.6mm American Depositary Shares (representing 4.6mm ordinary; includes partial exercise of the overallotment) at $14 apiece, the low end of the company’s intended $14-16 range.
Deal Industry
  • Biotechnology
    • Drug Discovery Tools
    • Large Molecule
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • IPO

Related Companies